LAMIVUDINE WITH EFAVIRENZ
Lamivudine with Efavirenz is a combination medication used in the treatment of HIV/AIDS. It combines Lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI), with Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI).Treatment of HIV-1 infection in adults and children.
Dosage varies based on individual patient factors and should be prescribed by a healthcare professional experienced in HIV treatment.
Dosage varies based on individual patient factors and should be prescribed by a healthcare professional experienced in HIV treatment.
Caution should be exercised in patients with hepatic impairment, psychiatric disorders, and those at risk for QT prolongation.
Common side effects may include nausea, headache, insomnia, and dizziness. Severe side effects such as hepatotoxicity and hypersensitivity reactions are possible.
Interacts with drugs metabolized by CYP3A4; caution with other antiretroviral agents and medications that prolong the QT interval.
